The expression and prognostic significance of bcl-2-associated transcription factor 1 in rectal cancer following neoadjuvant therapy
Contribuinte(s) |
University of Aberdeen, School of Biological Sciences University of Aberdeen, School of Biological Sciences, Biological Sciences University of Aberdeen, Medicine, Medical Sciences & Nutrition, Applied Medicine |
---|---|
Data(s) |
05/08/2016
05/08/2016
01/03/2016
20/03/2001
|
Resumo |
Date of Acceptance: 12/07/2015 © 2015 John Wiley & Sons Ltd. Acknowledgements This study was supported by funding from the Encompass kick start and SMART:Scotland award schemes of Scottish Enterprise and Friends of Anchor. The Grampian Biorepository assisted with the immunohistochemical investigations. Peer reviewed Postprint |
Formato |
11 |
Identificador |
Brown , G T , Cash , B , Alnabulsi , A , Samuel , L M & Murray , G I 2016 , ' The expression and prognostic significance of bcl-2-associated transcription factor 1 in rectal cancer following neoadjuvant therapy ' Histopathology , vol 68 , no. 4 , pp. 556-566 . , 10.1111/his.12780 0309-0167 PURE: 57922502 PURE UUID: c78601f1-4eb0-46b7-9b7c-36b106a24c2a PubMed: 26183150 |
Idioma(s) |
eng |
Relação |
Histopathology |
Direitos |
This is the peer reviewed version of the following article:Brown G T, Cash B, Alnabulsi A, Samuel L M & Murray G I (2016) Histopathology 68, 556–566. The expression and prognostic significance of bcl-2-associated transcription factor 1 in rectal cancer following neoadjuvant therapy, which has been published in final form at DOI: 10.1111/his.12780. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving." |
Palavras-Chave | #bcl-2-associated transcription factor 1 #biomarker #immunohistochemistry #monoclonal antibody #neoadjuvant therapy #prognosis #rectal cancer #QH301 Biology #QH301 |
Tipo |
Journal article |